Establishing the content validity of the kings health questionnaire in men and women with overactive bladder in the US

Patient

Volumn 4, Issue 3, 2011, Pages 177-187

  Margolis, Mary Kay ^a   Vats, Vasudha ^b   Coyne, Karin S ^a   Kelleher, Con ^c  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b PFIZER INC   (United States)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Overactive bladder; Quality of life

Indexed keywords

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTENT VALIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DESCRIPTIVE RESEARCH; EVALUATION; FEMALE; HUMAN; INTERVIEW; KING HEALTH QUESTIONNAIRE; MALE; NOCTURIA; OVERACTIVE BLADDER; PRIORITY JOURNAL; PSYCHOMETRY; QUALITATIVE ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SLEEP; SOCIAL LIFE; UNITED STATES; URINARY FREQUENCY; URINARY URGENCY; URINE INCONTINENCE;

CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; UNITED STATES; URINARY BLADDER, OVERACTIVE;

EID: 79960505325     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.2165/11586480-000000000-00000     Document Type: Article

References (26)

1. Irwin DE, Milsom I, Hunskaar S, et al.population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006 Dec; 50 (6): 1306-15 (Pubitemid 44692945)
2. Stewart WF, Van Rooyen JB, Cundiff GW, et al.prevalence and burden of overactive bladder in the United States. World J Urol 2003 May; 20 (6): 327-36 (Pubitemid 44175300)
3. Abrams P, ArtibaniW, Cardozo L, et al. Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn 2009; 28 (4): 287
4. Chiaffarino F, Parazzini F, Lavezzari M, et al. Impact of urinary incontinence and overactive bladder on quality of life. Eur Urol 2003 May; 43 (5): 535-8 (Pubitemid 36528441)
5. Liberman JN, Hunt TL, Stewart WF, et al. Health-related quality of life among adults with symptoms of overactive bladder: results from a US community-based survey. Urology 2001 Jun; 57 (6): 1044-50 (Pubitemid 32455563)
6. Coyne K, Revicki D, Hunt T, et al.psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 2002 Sep; 11 (6): 563-74 (Pubitemid 34876130)
7. Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999 Mar-Apr; 2 (2): 113-27
8. Wynd CA, Schmidt B, Schaefer MA. Two quantitative approaches for estimating content validity. West J Nurs Res 2003 Aug; 25 (5): 508-18 (Pubitemid 38569354)
9. Kelleher CJ, Cardozo LD, Khullar V, et al. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 1997 Dec; 104 (12): 1374-9 (Pubitemid 27517634)
10. Kobelt G, Kirchberger I, Malone-Lee J. Review: quality-oflife aspects of the overactive bladder and the effect of treatment with tolterodine. BJU Int 1999 Apr; 83 (6): 583-90 (Pubitemid 29164292)
11. Kochakarn W, Pummangura N, Kijvikai K, et al. Reliability of a Thai version of Kinǵs Health Questionnaire in Thai females with overactive bladder symptoms. J Med Assoc Thai 2005 Nov; 88 (11): 1526-34 (Pubitemid 44698965)
12. OkamuraK,Usami T,NagahamaK, et al. The relationships among filling, voiding subscores from International Prostate Symptom Score and quality of life in Japanese elderly men and women. Eur Urol 2002 Nov; 42 (5): 498-505 (Pubitemid 35396735)
13. Reese PR, Pleil AM, Okano GJ, et al. Multinational study of reliability and validity of the Kinǵs Health Questionnaire in patients with overactive bladder. Qual Life Res 2003 Jun; 12 (4): 427-42 (Pubitemid 36609887)
14. Tamanini JT, Dambros M, D́Ancona CA, et al. Concurrent validity, internal consistency and responsiveness of the Portuguese version of the Kinǵs Health Questionnaire (KHQ) in women after stress urinary incontinence surgery. Int Braz J Urol 2004 Nov-Dec; 30 (6): 479-86
15. Uemura S, Homma Y. Reliability and validity of Kinǵs Health Questionnaire in patients with symptoms of overactive bladder with urge incontinence in Japan. Neurourol Urodyn 2004; 23 (2): 94-100 (Pubitemid 38296192)
16. US Food and Drug Administration. Guidance for industry: patient-reported outcome measures. Use in medical product development to support labeling claims [online]. Available from URL: http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/UCM193282.pdf[Accessed 2010 Jan 1]
17. Homma Y, Kawabe K. Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial. World J Urol 2004 Oct; 22 (4): 251-6 (Pubitemid 41406544)
18. Junemann KP, Hessdorfer E, Unamba-Oparah I, et al.propiverine hydrochloride immediate and extended release: comparison of efficacy and tolerability in patients with overactive bladder. Urol Int 2006; 77 (4): 334-9 (Pubitemid 44837003)
19. Kelleher CJ, Kreder KJ, Pleil AM, et al. Long-term healthrelated quality of life of patients receiving extended-release tolterodine for overactive bladder. Am JManag Care 2002 Dec; 8 (19 Suppl.): S616-30 (Pubitemid 36050143)
20. Kelleher CJ, Reese PR, Pleil AM, et al. Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder. Am J Manag Care 2002 Dec; 8 (19 Suppl.): S608-15 (Pubitemid 36050142)
21. Payne CK, Kelleher C. Redefining response in overactive bladder syndrome. BJU Int 2007 Jan; 99 (1): 101-6 (Pubitemid 44915628)
22. Pleil AM, Reese PR, Kelleher CJ, et al. Health-related quality of life of patients with overactive bladder receiving immediate-release tolterodine. HEPAC 2001; 2: 69-75 (Pubitemid 33014732)
23. Sand PK, Goldberg RP, Dmochowski RR, et al. The impact of the overactive bladder syndrome on sexual function: a preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial. Am J Obstet Gynecol 2006 Dec; 195 (6): 1730-5 (Pubitemid 44792663)
24. Wang AC, Chih SY, Chen MC. Comparison of electric stimulation and oxybutynin chloride in management of overactive bladder with special reference to urinary urgency: a randomized placebo-controlled trial. Urology 2006 Nov; 68 (5): 999-1004 (Pubitemid 44750132)
25. Wang AC,WangYY, Chen MC. Single-blind, randomized trial of pelvic floor muscle training, biofeedback-assisted pelvic floor muscle training, and electrical stimulation in the management of overactive bladder. Urology 2004 Jan; 63 (1): 61-6
26. Coyne K, Margolis MK, Weinstein D, et al. Health-related quality of life differences between men and women with OAB treated with fesoterodine. IUGA 33rd Annual Meeting; 2008 Sep 15-17; Taipei